Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction
The MUNICON trial confirmed prospectively the usefulness of early response evaluation by 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography (FDG-PET) . Metabolic responders (R) showed initially a higher FDG uptake compared with nonresponders (p = 0.018). An association of the vascular end...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2011
|
| In: |
Molecular imaging & biology
Year: 2011, Volume: 13, Pages: 178-186 |
| ISSN: | 1860-2002 |
| DOI: | 10.1007/s11307-010-0330-0 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11307-010-0330-0 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s11307-010-0330-0 
|
| Author Notes: | Sylvie Lorenzen, Ben Panzram, Gisela Keller, Florian Lordick, Ken Herrmann, Karin Becker, Ruppert Langer, Markus Schwaiger, Jorg Rudiger Siewert, Katja Ott |
| Summary: | The MUNICON trial confirmed prospectively the usefulness of early response evaluation by 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography (FDG-PET) . Metabolic responders (R) showed initially a higher FDG uptake compared with nonresponders (p = 0.018). An association of the vascular endothelial growth factor (VEGF) 936C>T polymorphism and FDG uptake was reported for breast cancer. Therefore, we investigated the VEGF 936C>T polymorphism for an association with response and survival. |
|---|---|
| Item Description: | Published online: 7 May 2010 Gesehen am 10.10.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1860-2002 |
| DOI: | 10.1007/s11307-010-0330-0 |